Straumann Holding AG EBITDA 2012-2025 | SAUHY
Straumann Holding AG annual and quarterly EBITDA history from 2012 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Straumann Holding AG EBITDA for the quarter ending December 31, 2025 was $0M, a 0% increase year-over-year.
- Straumann Holding AG EBITDA for the twelve months ending December 31, 2025 was $0M, a 0% increase year-over-year.
- Straumann Holding AG 2025 annual EBITDA was $0.854B, a 0.77% increase from 2024.
- Straumann Holding AG 2024 annual EBITDA was $0.847B, a 40.55% increase from 2023.
- Straumann Holding AG 2023 annual EBITDA was $0.603B, a 17.59% decline from 2022.
|
Straumann Holding AG Annual EBITDA (Millions of US $) |
|
|---|---|
| 2025 | $854 |
| 2024 | $847 |
| 2023 | $603 |
| 2022 | $731 |
| 2021 | $707 |
| 2020 | $273 |
| 2019 | $484 |
| 2018 | $404 |
| 2017 | $329 |
| 2016 | $257 |
| 2015 | $214 |
| 2014 | $193 |
| 2013 | $156 |
| 2012 | $100 |
| 2011 | $175 |
|
Straumann Holding AG Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-12-31 | |
| 2024-12-31 | |
| 2024-06-30 | |
| 2023-12-31 | |
| 2022-12-31 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| 2020-06-30 | |
| 2019-12-31 | |
| 2018-12-31 | |
| 2017-12-31 | |
| 2017-06-30 | |
| 2016-12-31 | |
| 2016-06-30 | |
| 2015-12-31 | |
| 2014-12-31 | |
| 2013-12-31 | |
| 2013-06-30 | |
| 2012-12-31 | |
| 2012-06-30 | |
| 2011-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $16.902B | $3.144B |
| The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |